Alseres Pharmaceuticals Inc. (ALSE) Stock Quote

Detailed Quote for Alseres Pharmaceuticals Inc. (ALSE)

close 52 Week Information

52 Week High

January 27, 2012

Close: 0.51

52 Week Low

September 16, 2011

Close: 0.015

Today

5d

1m

3m

1y

more

Last Price
0.211

Change $

Change %

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
N/A

High
N/A

Low
N/A

Prev Close
0.211

Last Trade
2/9/12

Volume
0

52 Wk Hi
0.51

52 Wk Low
0.015

Market Cap
6.7 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
31,744,145

EPS (TTM)
-0.12

PE Ratio
N/A

close Exchange Information Listed On OTCQB - U.S. Registered (OTCQB) Exchange
OTCQB

News and Media for Alseres Pharmaceuticals Inc. (ALSE)

Sector News | Topic News

Tags for Alseres Pharmaceuticals Inc.

Research stocks or mutual funds related to Alseres Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to ALSE. The keywords below have been associated to ALSE by either user submission or electronic means.

parkinsons disease clinical trial logistics pharmaceuticals research pharmaceuticals international research cubist pharmaceuticals pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics clinical research consulting pharmaceutical research and development dupont pharmaceuticals pharma marketing pharma license pfizer pharmaceutical company neurodegenerative diseases treatment for parkinson's pharmaceutical sales pharma in licensing history of pharmaceuticals licensing companies biotech corporation pharmaceutical development pharmaceutical reports pharmaceutical magazine physician clinical trials Drugs pharma clinical trials pharmaceutical manufacturing software parkinson's disease support pharmaceutical manufacturing specialty pharmaceuticals medical device clinical trial contract pharmaceutical pharmaceutical consulting pharmaceutical industry clinical trials europe pharmaceutical advances pharmaceutical out licensing neurodegenerative disorders Healthcare pharmaceutical sector bio pharmaceuticals pharmaceutical innovation jobs in pharmaceuticals pharmaceutical pfizer pharma pharmaceutical industry research Parkinson disease pharmaceutical licensing

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.